Daily Health News Issue # 319 for 10/1/2025

Editor's Note: We are back to a federal government shutdown – the first since 2018 (that one was over border wall funding, and lasted 35 days).  The key hangup this time seems to be the planned expiration of "COVID era" ACA health subsidies.  The dispute is not about elimination of ACA subsidies – it is about the rollback of those subsidies to pre-COVID levels.  Both parties are nervous as to how this rollback will impact working voters. Senator Roger Marshell (R-KS) is attempting to compromise with Democrats on the issue, by limiting ACA subsidies to families at 400% or lower of the Federal Poverty Level.

The other big news revolves around drug costs.  TrumpRx is a website planned to go live in 2026 and will allow users to get certain drugs at discounted prices (including GLP-1 meds like Zepbound) directly from the pharma company.  However, if you have a health plan with prescription drug benefits, this site might not do a lot for you.  For example, I know one guy (me) that gets a monthly injection with a drug that costs over $1,300 a dose.  I pay $5 after my Medicare Part B pays.  I don't think my drug will be on TrumpRx for $4, but who knows.

Pfizer also announced a deal with President Trump for 'most favored' drug pricing for Medicaid. That, along with other commitments, means Pfizer will get a break on tariffs.

Our Verizon Optical Network Connector here at HAPCO HQ failed so our broadband is out .  Never fear, we are pushing this out via cellular. Neither sleet nor rain nor faulty fiber can stop C.R.A.P.!

Today's Quote:

"The warning that I received, you may take with however many grains of salt you wish, that the brown acid that is circulating around us is specifically not too good. It's suggested that you do stay away from that; of course, it's your own trip, so, be my guest. But, please be advised that there is a warning on that one." … â€“ Chip Monck, Woodstock announcer (1969).

Across the 64 articles curated today, here are the top 3 themes:

  • Government funding crisis threatens healthcare programs and workforce stability
  • Drug pricing initiatives and direct-to-consumer pharmaceutical models reshape market access
  • Artificial intelligence deployment expands across clinical care, administration, and patient self-management

Today's Top Articles

Of the 64 articles curated today, here are the top 8 in our judgment:

Article_Title Article_Takeaway
Marshall sketches possible ACA subsidy compromise Sen. Marshall is open to a compromise on ACA subsidies, suggesting a return to the 400% poverty level income cap.
Opioid use disorder cases jumped post-pandemic Diagnoses of opioid use disorder among the commercially insured rose nearly 40% nationwide from 2021 to 2024, per FAIR Health data.
What the government shutdown could mean for healthcare A government shutdown looms, but Medicare, CHIP, and Medicaid are shielded, though HHS may furlough 41% of its workforce.
Medicaid Experiment Falls Flat on Both Promises Georgia’s Medicaid work requirements failed to increase employment or coverage, raising concerns about a nationwide mandate set for 2026.
TikTok ecoinfluencers promote misinformation about child health A study reveals TikTok ‘ecoinfluencers’ are spreading potentially harmful misinformation about child health, often contradicting scientific evidence.
The Health Insurance Subsidies at the Center of the Government Shutdown Fight Enhanced ACA subsidies’ potential expiration at the end of 2025 is a key point of contention in the government shutdown fight, with millions at risk of losing coverage.
How Trump’s Drug-Buying Site ‘TrumpRx’ Will Work TrumpRx, a new drug-buying site, may not save insured Americans money, but could help the uninsured access discounted medications.
Patients Are Diagnosing Themselves With Home Tests, Devices and Chatbots Patients are increasingly using DIY healthcare options like home tests and AI chatbots due to doctor shortages and a rise in self-care.

Today's Graphic



Medical Malpractice Events by Type 2020-2024 (Source: Coversys 8/25).  See below or click here 



Today's Graphic

Today's Digest

Here is a summary of all 64 articles curated today into the Competitive Research Analytics Platform for 10/1/2025:

 Enhanced ACA subsidies expire at year-end while government shutdown threats loom, potentially furloughing over 32,000 HHS workers and disrupting Medicare waiver programs. 

Health systems are dropping Medicare Advantage plans due to prior authorization denials and payment delays, while work requirements for Medicaid show no evidence of increasing coverage or employment. 

The Trump administration's TrumpRx website and Pfizer pricing deal aim to reduce drug costs, though benefits for insured patients remain unclear. European pharma stocks surged on this news. 

AI integration accelerates across healthcare—from diagnosis and prior authorization to patient self-care tools and senior living solutions. Home health services expand despite federal funding cuts as systems seek cost efficiencies. 

Workforce shortages drive innovation in care delivery models and DIY healthcare adoption. 

Legal battles intensify, including a $500M fraud judgment against Universal Health Services and whistleblower suits involving UnitedHealth. Data security breaches expose 150,000 patient records. 

State-level responses diverge sharply along partisan lines regarding Medicaid expansion, work requirements, and federal policy impacts. Meanwhile, specialized care needs emerge for seniors facing anaphylaxis risks, children exposed to health misinformation on TikTok, and rising opioid use disorder diagnoses.

See back issues of Daily C.R.A.P. on our website right here in the archive.

As of today, C.R.A.P. now has 173 subscribers

Want to drop us a line? E-Mail Us

Click here for ALL articles added to C.R.A.P. in the past 24 hours

Similar Posts

Leave a Reply